INJURY PRIMES B-CELLS FOR INFLAMMATORY CYTOKINE PRODUCTION.

2005 ◽  
Vol 33 ◽  
pp. A33
Author(s):  
Malcolm MacConmara ◽  
Satoshi Fujimi ◽  
Adrian A Maung ◽  
Peter H Lapchak ◽  
Adam Delisle ◽  
...  
Bone ◽  
2009 ◽  
Vol 44 ◽  
pp. S139
Author(s):  
L. Danks ◽  
S. Workman ◽  
V. Nicolaidou ◽  
D. Webster ◽  
B. Foxwell ◽  
...  

2009 ◽  
Vol 131 ◽  
pp. S21
Author(s):  
Madhumita Jagannathan ◽  
Hyunjin Shin ◽  
Yue Zhang ◽  
Hatice Hasturk ◽  
Alpdogan Kantarci ◽  
...  

Bone ◽  
2009 ◽  
Vol 44 ◽  
pp. S216
Author(s):  
L. Danks ◽  
S. Workman ◽  
V. Nicolaidou ◽  
D.A. Webster ◽  
B.M. Foxwell ◽  
...  

eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Takemichi Fukasawa ◽  
Ayumi Yoshizaki ◽  
Satoshi Ebata ◽  
Asako Yoshizaki-Ogawa ◽  
Yoshihide Asano ◽  
...  

Despite antigen affinity of B cells varying from cell to cell, functional analyses of antigen-reactive B cells on individual B cells are missing due to technical difficulties. Especially in the field of autoimmune diseases, promising pathogenic B cells have not been adequately studied to date because of its rarity. In this study, functions of autoantigen-reactive B cells in autoimmune disease were analyzed at the single-cell level. Since topoisomerase I is a distinct autoantigen, we targeted systemic sclerosis as autoimmune disease. Decreased and increased affinities for topoisomerase I of topoisomerase I-reactive B cells led to anti-inflammatory and pro-inflammatory cytokine production associated with the inhibition and development of fibrosis, which is the major symptom of systemic sclerosis. Furthermore, inhibition of pro-inflammatory cytokine production and increased affinity of topoisomerase I-reactive B cells suppressed fibrosis. These results indicate that autoantigen-reactive B cells contribute to the disease manifestations in autoimmune disease through their antigen affinity.


Sign in / Sign up

Export Citation Format

Share Document